Bringing the woolly mammoth back to life is no easy task. But for Ben Lamm, CEO of Colossal Biosciences, the stress of the ...

Colossal Biosciences, a Texas-based company, genetically engineered a woolly mouse, marking an achievement toward its goal of ...

Colossal Biosciences cofounder and CEO Ben Lamm is worth $3.7 billion following the company's recent fundraise at an eye-popping $10.2 billion valuation. But it has yet to be paid for reviving extinct ...

Colossal Biosciences genetically engineered a ‘woolly mouse’ with mammoth traits. The milestone could inform human gene therapy.

The journey to the woolly mouse began with the woolly mammoth. Scientists at Colossal examined more than 100 genomes of Asian ...

US biotechnology company Colossal Laboratories and Biosciences has a radical proposal: it wants to resurrect the woolly ...

Better to safeguard our existing animals and the Earth than resurrect extinct species or flee to another planet.

Since Colossal Biosciences launched in 2021, it’s skyrocketed to a $10.2 billion valuation to fund its mission of de-extinction. For Colossal, it’s more than the buzzy headlines that its ...

WASHINGTON (AP) — Extinction is still forever, but scientists at the biotech company Colossal Biosciences are trying what they say is the next best thing to restoring ancient beasts ...

DALLAS, Texas. (WFLA) — Scientists at biotech company Colossal Biosciences were able to produce genetically modified mice, a successful feat in their ongoing conservation and de-extinction efforts.

We all watch movies like Jurassic Park and Jurassic World and marvel at the possibilities of bringing back animals and ...